Introduction
============

The prevalence of hypertension in the general population is \~30%--45% and increases with age. According to the World Health Organization (WHO) data, hypertension is found in 47% of the population in underdeveloped or developing countries and in 49% in developed countries.[@b1-ppa-10-2437] The number of adults with hypertension is predicted to increase by 60% by the year 2025, to a total of 1.56 billion adults.[@b1-ppa-10-2437]

The population-wide effectiveness of hypertension treatment is still insufficient. The primary factor contributing to an unsatisfactory response to pharmaceutical treatment is poor medication adherence. The management and control of hypertension are possible with a combination of medication and strict lifestyle changes. Published studies indicate that \~60% of patients treated for hypertension discontinue treatment within 6 months.[@b2-ppa-10-2437] Apart from adverse effects and inadequate blood pressure (BP) control despite treatment, the most common causes of lack of adherence are believed to include a lack of patient involvement in the treatment process or motivation to continue it and a lack of information on the disease and its treatment, especially detailed information on dosage.[@b3-ppa-10-2437]

An important component to control hypertension is knowledge, which is relative to lower rates of ceasing interventions, following the interventions behavior, and better control on disease by patients. As a result, careful evaluation of hypertension has been considered as an inseparable part of general care of the patients.

This results from poor awareness of the consequences of nontreatment, mistrust of the physician, and negating the necessity of treatment when symptoms are not present.[@b4-ppa-10-2437] Other than deficits in knowledge, factors of significance for adherence are reported to include sociodemographic and clinical (comorbidities, multidrug treatment) characteristics, as well as patients' health-related beliefs.[@b5-ppa-10-2437],[@b6-ppa-10-2437]

Observations indicate that patients with hypertension are least knowledgeable on normal BP values and on lifestyle changes required during the treatment process.[@b7-ppa-10-2437] The appropriate lifestyle changes are fundamental for preventing hypertension. Clinical studies prove that appropriate lifestyle modifications can have a hypotensive effect comparable to be seen with single-agent pharmaceutical treatment.[@b8-ppa-10-2437] Lifestyle changes may be a safe and effective way of preventing or delaying hypertension, avoiding or delaying pharmaceutical treatment in patients with grade 1 hypertension, and reducing BP in patients who are already treated, which allow dosages of hypotensive drugs to be reduced.[@b9-ppa-10-2437]

European Society of Cardiology (ESC) guidelines include salt restriction, moderation of alcohol consumption, high consumption of vegetables and fruits and low-fat diet, weight reduction and maintenance, and regular physical exercise as lifestyle measures that have been shown to be capable of reducing BP.[@b10-ppa-10-2437]

In Poland, hypotensive drug treatment is found to be effective in 28% of male and 29% of female patients.[@b11-ppa-10-2437] At the same time, as many as 39% of men and 29% of women diagnosed with hypertension do not start their treatment, which indicates poor awareness of long-term complications of hypertension.[@b11-ppa-10-2437] Epidemiological studies performed in Europe and in the United States demonstrate that a higher effectiveness of hypertension treatment -- as high as 63% -- is achievable. The European Society of Hypertension (ESH) and the Polish Society of Hypertension consider patient education aimed at enhancing their knowledge and motivation, and covering especially non-pharmaceutical treatment, to be a primary method of managing all patients with hypertension.[@b12-ppa-10-2437] Such patients should be managed by a therapeutic team. Nursing assistance may prove particularly significant in the process of lifestyle modification, where long-term adherence remains very low. Published studies demonstrate that team-based care is more effective than standard treatment, especially if it involves nurses and/or pharmacists.[@b13-ppa-10-2437] The beneficial effect of the involvement of pharmacists and nurses has been obtained when their tasks involved patient education, behavioral and medical counseling, assessment of adherence to treatment, and, for pharmacists, interaction with physicians in the area of guideline-based therapy.[@b13-ppa-10-2437]--[@b15-ppa-10-2437]

The papers on the level of knowledge of Polish patients prove the insufficient knowledge on arterial hypertension (AH) and its complications.[@b16-ppa-10-2437] The connection between sociodemographic variables and the level of knowledge on hypertension is widely discussed in the literature.[@b17-ppa-10-2437],[@b18-ppa-10-2437] However, there are small number of papers focusing on the association between the level of knowledge and the adherence to drug recommendations. Information on relationship between patients' knowledge on hypertension and adherence may be helpful in the prevention of complication, treatment planning, and better patient health control.

The purpose of the study was to investigate the relationship between knowledge on hypertension and on its management, and adherence to pharmaceutical treatment in hypertension.

The investigation included the following questions: What is the knowledge level of Polish patients with hypertension treated with at least one hypotensive drug?How does adherence differ depending on knowledge regarding hypertension?Does a correlation exist between knowledge and adherence, and what other variables affect adherence?

Materials and methods
=====================

Participants
------------

The study was performed in the Kosmonautów health center in Wroclaw. Data were collected from January 2015 through November 2015. Eligible patients were consecutively selected by the physicians, who informed them of the study objectives and recruited all patients who agreed to participate. All the study participants gave informed consent. The survey included 233 patients (124 females) aged between 32 and 90 years (mean age 63±15 years) diagnosed with hypertension at least 1 year before (which is in line with the ESH guidelines),[@b10-ppa-10-2437] treated for hypertension with at least one hypotensive agent, and who had been patients of the health center for at least 6 months.

The inclusion criteria were as follows: 1) clinically confirmed hypertension diagnosis, 2) the patient's written informed consent, and 3) age ≥18 years. The exclusion criteria were as follows: 1) moderate to severe dementia (defined as mini-mental score ≤15),[@b19-ppa-10-2437] 2) lack of consent, and 3) patients with severe concomitant diseases, which could affect adherence to therapeutic guidelines, were excluded from the study due to their complex treatment schemes and the possibility of adverse effects and reactions occurring as a result of the use of multiple medications. Patients were selected by a panel consisting of a physician and a nurse -- specialist in the field of cardiac nursing. The sample group was homogeneous and could be subjected to statistical analysis.

Patients were divided into two groups based on their knowledge level. The patients' knowledge was assessed using the Polish version of the Hypertension Knowledge-Level Scale (HK-LS). According to the asymmetrical answer distribution ([Figure 1](#f1-ppa-10-2437){ref-type="fig"}), the group was divided into two subgroups depending on the score: ≤17 points -- low level of knowledge on hypertension (n=147);between 18 and 22 points -- high level of knowledge on hypertension (n=86).

Ethical consideration
---------------------

The study was approved by the Bioethics Committee (approval no KB 136/2015); all patients recruited to the study provided their informed and voluntary written consent to participate in the study.

Instruments
-----------

Two validated instruments were used: the 8-item © Morisky Medication Adherence Scale (MMAS-8) and the HK-LS. Furthermore, the patients were interviewed and their medical records were analyzed to gather detailed information. The instruments were distributed by a cardiac nurse during patients' follow-up appointments for continuing hypotensive treatment.

Adherence
---------

Self-reported medication adherence was assessed using the MMAS-8, previously translated and validated. Self-reported MMAS-8 is simple to administer and is feasible and economical in clinical practice. The MMSA-8 was designed to facilitate the identification of barriers to and behaviors associated with adherence to chronic medication.[@b20-ppa-10-2437],[@b21-ppa-10-2437] The tool has been confirmed as reliable and significantly associated with BP control in individuals with hypertension, as well as with antihypertensive medication pharmacy fill rates. MMAS-8 scores may range from 0 to 8, with scores of \<6, 6--8, and 8 reflecting low, medium, and high adherence, respectively.[@b22-ppa-10-2437] The questionnaire has very good psychometric properties (Cronbach' s alpha =0.81).

Knowledge
---------

The HK-LS assessed respondents' knowledge in defining hypertension, lifestyle, medical treatment, drug compliance, diet, and complication of hypertension. Each item was a full sentence that was either correct or incorrect. And each item was prepared as part of a standard answer (correct, incorrect, or do not know). To assess the content validity of the scale to identify whether items were or were not representative of the knowledge level of hypertension, the opinions of experts were requested through an assessment form. The expert opinions were Evaluated and in the Polish language version provided all the questions.

The scale included 22 items divided into six subdimensions. The expressions are incorrect in nine items. Each correct answer is worth 1 point. Incorrect statements are encoded inversely to the other items. The maximum score is 22 for the entire scale. The minimum score is zero for the entire scale and for all subdimensions.[@b23-ppa-10-2437] The questionnaire has adequate psychometric properties (Cronbach's alpha =0.81).

Possible determinants of adherence
----------------------------------

Variables that may affect the aspects of adherence studied include ESC hypertension grade, disease duration, type of treatment and of hypotensive drugs administered, presence of comorbidities, self-control and keeping a self-control journal, and sociodemographic factors (age, sex, living situation, and education).

Statistical analysis
--------------------

The level of knowledge was evaluated by the HK-LS questionnaire. The maximum score was 22 points. The distribution of scores obtained is shown on the histogram in [Figure 1](#f1-ppa-10-2437){ref-type="fig"}. The distribution is highly asymmetrical, with a left skew, that is, a small proportion of low scorers. Therefore, at a further stage, the following classification criteria were used: ≤17 points -- low level of knowledge on hypertension, points between 18 and 22 -- high level of knowledge on hypertension.

For quantitative variables, the normality of empirical distributions was verified using the Shapiro--Wilk test. Subsequently, mean values and standard deviations were calculated, and mean values were compared between the two patient groups in one-way analysis of variance. If the null hypothesis of no differences between groups was rejected, post hoc tests were performed (multiple comparisons: least significant difference).

Qualitative and ordinal variables were grouped in contingency tables, with numbers (n*~i~*) and fractions calculated. The independence of qualitative characteristics was verified using Pearson's chi-squared test. The strength of correlations was determined by calculating Spearman's rank correlation coefficients (*ρ*) and significance levels (*P*).

The correlation of the independent variables of adherence was tested in multiple linear regression analysis using the forward stepwise method, after testing the applicability of the least squares method and performing analyses of outliers. For independent variables (knowledge and age), standardized coefficients and regression coefficients *b* were calculated. The statistical significance of variables in the model was verified using Student's *t*-test. The quality of the proposed multiple linear regression model was evaluated using standard error of the estimate (SE~e~). Calculations were performed using the STATISTICA Version 10 software suite.

Results
=======

Patient characteristics
-----------------------

In the group of 233 patients studied, 63% showed a low level of knowledge on hypertension. In the sociodemographic analysis, the only factor for which differences were found was the patients' living situation. The majority of patients with a low level of knowledge on hypertension were living alone (83.7% vs 15.1%; *P*=0.045) ([Table 1](#t1-ppa-10-2437){ref-type="table"}).

Analysis of the patients' clinical characteristics showed that the low knowledge level group had a higher rate of ischemic heart disease (31.3% vs 15.1%; *P*=0.01). A total of 56.5% patients with a low knowledge level and 27.9% patients with high knowledge level group had elevated BP (systolic ≥140 mmHg and/or diastolic ≥90 mmHg). Thirty-five percent of patients with a low knowledge level and fifty-eight percent of patients with high knowledge level had their BP controlled at least daily/weekly. Patients with low knowledge level had less often stated that they owned a BP meter than patients with high knowledge level (58.5% vs 77.1%) ([Table 2](#t2-ppa-10-2437){ref-type="table"}).

Characteristics of adherence and knowledge
------------------------------------------

Most respondents had moderate adherence scores, but in group with low knowledge level, they have lower adherence than in group in high knowledge level MMAS (6.45±1.45 vs 7.08±1.04; *P*=0.038). However, the low knowledge level group included significantly more low-adherence patients than the group with a high level of knowledge (19.7% vs 8.1%; *P*=0.023) ([Table 2](#t2-ppa-10-2437){ref-type="table"}).

The number (proportion) of correct answers to each HK-LS item are shown in [Table 3](#t3-ppa-10-2437){ref-type="table"}. Patients with a low knowledge level answered correctly significantly less frequently than those with a high knowledge level (*P*\<0.01), the only exception being item 6, with a similar proportion of correct answers in the two groups (*P*\>0.05) ([Table 3](#t3-ppa-10-2437){ref-type="table"}).

The analysis of questionnaire answers showed that in the low knowledge level group, the largest proportion of wrong answers was provided for items on non-pharmaceutical hypertension treatment, and the lowest scores were obtained in the "diet" domain (0.49±0.64 vs 1.33±0.73; *P*\<0.001), then in the "definition" (1.70±0.65 vs 1.92±0.28; *P*=0.012) and "drug adherence" (2.19±1.14 vs 3.40±0.69; *P*\<0.001) domains. The highest scores were obtained in the "complications" domain (4.05±1.46 vs 4.93±0.26; *P*\<0.001). The total score in the low knowledge level group was 13.8±3.7 and that in the high knowledge level group was 19.1±1.1 ([Figure 2](#f2-ppa-10-2437){ref-type="fig"}).

In the group of 233 patients, 71.5% of answers were correct, whereas in the subgroups the percentages were 62.6 (low knowledge level) and 86.5 (high knowledge level). In the low knowledge level group, the lowest proportion of correct answers was given in the "diet" (24.5% vs 66.3% in the high knowledge level group) and "drug adherence" (54.8% vs 84.9%) domains. In the low knowledge level group, the highest proportion of correct answers was given in the "definition" domain (85%), whereas in the high knowledge level group, the highest proportion of items answered correctly belonged to the "complications" domain (98.6%). The significance of differences was *P*\<0.001 ([Table 4](#t4-ppa-10-2437){ref-type="table"}) ([Figure 3](#f3-ppa-10-2437){ref-type="fig"}).

Single-factor analysis -- correlation on adherence of the characteristics studied (MMAS-8 score)
------------------------------------------------------------------------------------------------

Subsequently, Spearman's rank analysis was performed to evaluate the correlation of selected variables on adherence (MMAS-8 score). [Table 5](#t5-ppa-10-2437){ref-type="table"} shows correlation coefficients from the analysis. Correlation analysis showed that variables having a significant positive effect on adherence included regular BP measurement (*ρ*=0.171, *P*=0.009); keeping a self-control diary (*ρ*=0.017, *P*=0.007); adherence with non-pharmaceutical hypertension treatment (*ρ*=0.182; *P*=0.006); and a high level of knowledge on hypertension (HK-LS) (*ρ*=0.173; *P*=0.008) ([Table 5](#t5-ppa-10-2437){ref-type="table"}).

Statistically significant independent determinants of good adherence include a high level of knowledge on hypertension (*β*=0.208; *P*=0.001), non-pharmaceutical hypertension treatment (*β*=0.171; *P*=0.006); and regular BP measurements (*β*=0.183; *P*=0.004). The model is significant: *F*(4.228)=8.99; *P*\<0.001, but only explains 36.9% of the variation in adherence scores. $$\text{Adherence} = 1.72 + 0.25 \times \text{non-pharmaceutical~hypertension} + 0.28 \times \text{high~level~of~knowledge~on~hypertension}\  + \ 0.08\  \times \ \text{regular~BP~measurements}$$

Spearman's rank analysis of the correlation of knowledge on specific HK-LS domains on medication adherence showed a statistically significant correlation between knowledge in the "drug adherence" domain and adherence measured by the MMAS questionnaire, especially in the low knowledge level group (*ρ*=0.303; *P*\<0.001). In the entire study group, a significant correlation between knowledge and adherence was observed. Higher knowledge levels were correlated with better adherence, that is, higher MMAS-8 scores (*ρ*=0.179; *P*=0.007) ([Table 6](#t6-ppa-10-2437){ref-type="table"}).

Discussion
==========

Poorly controlled or untreated hypertension causes gradual irreversible organ damage, leading to life-threatening complications or even death. Hypertension treatment involves continued drug administration, as well as lifestyle modifications and adherence with a complex set of therapeutic recommendations: reduced salt and animal fat intake, weight reduction, and regular exercise. Poor knowledge on adherence to the treatment plan negatively affects patient awareness and behaviors and poses a significant problem in hypertension control. Knowledge and education are considered crucial for proper hypertension control.[@b24-ppa-10-2437] In the present study, as many as 63% of patients showed a low level of knowledge on the definition, treatment, and complications of hypertension. Other published studies confirm the poor knowledge on hypertension among patients[@b25-ppa-10-2437] and a lack of appropriate education promoting the understanding of hypertension.[@b26-ppa-10-2437],[@b27-ppa-10-2437]

In the patients with hypertension group of the study, knowledge was poorest with regard to diet and adherence and best with regard to complications. In a study by Eshah and Al-Daken,[@b28-ppa-10-2437] the lowest knowledge levels were found in the "diet" domain, as in the present study, and in the "definition" domain, in contrast to this study. Furthermore, contrary to this study, other authors reported highest knowledge levels in the "lifestyle" and "drug adherence" domains.[@b29-ppa-10-2437] According to other authors, being hypertensive increases the patient's level of knowledge regarding the illness[@b30-ppa-10-2437],[@b31-ppa-10-2437] and motivation to learn more. In the present study, all patients had been diagnosed with hypertension at least 1 year before, and more than half of them still showed an unsatisfactory level of knowledge on the definition, treatment, and complications of hypertension. In the low knowledge level group, only 62% of questionnaire items were answered correctly, with the lowest correct answer percentage in the "diet" domain -- 24.5.

Nearly 20% of patients with a low knowledge level and 8% of patients with a high knowledge level had low adherence scores. The present findings corroborate those by other authors, reporting lack of adherence among patients with hypertension at 25%[@b31-ppa-10-2437] and 28%,[@b5-ppa-10-2437] with better results among patients who were more knowledgeable on the disease.[@b31-ppa-10-2437]

In the study by Karaeren et al,[@b31-ppa-10-2437] knowledge on the causes of hypertension and reasons for hypotensive treatment was positively correlated with medication adherence. In the present study, the overall knowledge score and the "drug adherence" domain score were positively correlated with medication adherence. In other studies, knowledge on hypertension complications was not found to be correlated with adherence, which is surprising, as it could be assumed to be the primary motivation for changes in behavior.[@b31-ppa-10-2437] In the present study, knowledge was the highest in the "complications" domain in both groups, and the score in this domain was a predictor of good adherence. In this aspect, the present findings differ from other published reports, where patients were interested in short-term problems related to hypertension (symptoms and adverse effects of treatment) rather than long-term complications.[@b31-ppa-10-2437]--[@b33-ppa-10-2437] In the current study, single- and multiple-factor analyses showed significant correlation of knowledge in the "drug adherence" domain on actual medication adherence. The authors state that many patients with hypertension do not understand that hypotensive medication should be taken throughout their life, as opposed to medication during symptom exacerbations[@b31-ppa-10-2437],[@b34-ppa-10-2437] and discontinuation when BP values are normal. In a study by Kjellgren et al[@b35-ppa-10-2437] treatment side effects and disease symptoms were correlated with lack of adherence to treatment. In this study, the impact of adverse effects of treatment was not assessed; however, the "drug adherence" domain was a determinant of high adherence. Items comprised in the "drug adherence" domain are consistent with the correlation between non-pharmaceutical treatment for hypertension (salt restriction and exercise) and self-reported medication adherence, found in this study. Patients complying with non-pharmaceutical treatment recommendations were found to have better adherence to pharmaceutical treatment.

Blood pressure control involves such aspects as regular medication-taking, BP measurements, and keeping a diary of self-control.[@b33-ppa-10-2437] In the present study, regular BP measurements and diary of self-control keeping were confirmed to be predictors of high medication adherence.

Medication adherence is crucial to hypertension control and cardiovascular complication prevention. Concurrent ischemic heart disease is a significant independent negative determinant of medication adherence. In a study by Zhao et al,[@b37-ppa-10-2437] 38.4% of patients with ischemic heart disease failed to comply with treatment, and poor knowledge on treatment and complications was correlated with poor medication adherence. The negative correlation between ischemic heart disease and patients with hypertension knowledge could, or should, be explained by the frequent occurrence of ischemic heart disease as a complication of untreated hypertension.[@b36-ppa-10-2437]

It should be emphasized that no association between sociodemographic variables and the level of adherence to drug recommendations was discovered in our study. Only regular BP measurement and the concurrent non-pharmaceutical treatment as well as the high level of knowledge were statistically significant factors influencing the level of adherence to recommendations. Both in our study and in the literature the association between the lower level of BP control (or total lack of BP control) with lower level of adherence to recommendations was confirmed.[@b38-ppa-10-2437],[@b39-ppa-10-2437]

During hypotensive therapy, the detection of non-adherence in patients with noncontrolled AH is very important before increasing the dosage of the drugs. In such a situation, increasing the dosage of the drugs might intensify the side effects of the medication and increase the level of non-adherence to recommendation. Only effective communication and education can influence the regular BP control and the adherence to therapeutic recommendations.

Conclusion
==========

1.  Patients with hypertension knowledge on their illness are insufficient, with the lowest levels of knowledge on diet and drug adherence.

2.  Patients with a high level of knowledge also show better medication adherence.

3.  Knowledge on hypertension is a significant independent determinant of good adherence. Other independent determinants include salt restriction and regular BP measurements.

4.  Concurrent ischemic heart disease is a significant negative determinant.

Implication for practice
------------------------

The identification of knowledge deficits as a factor contributing to lack of adherence and poor hypertension control remains a key challenge for clinicians caring for patients with hypertension.

A multidisciplinary approach and the development of intervention programs focused on promoting patient knowledge and healthy behaviors are significant components of care, contributing to better adherence and control.

Study limitations
-----------------

The most important limitation is the fact that this study sample was recruited from a single center. Then, the method used for assessing adherence was a self-assessment questionnaire; however, the MMAS had been used in multiple studies on medication adherence in hypertension, showing good psychometric properties. Finally, no information on patients' sources of knowledge was gathered.
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![Histogram of hypertension knowledge scores obtained by 233 patients.\
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![Comparison of correct answer proportions for each HK-LS item in the two groups differentiated by their level of knowledge on hypertension (items with \<50% correct answers are marked in red).\
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![Comparison of correct answer percentages in the 6 HK-LS domains between the two groups differentiated by their level of knowledge on hypertension.\
**Abbreviation:** HK-LS, Hypertension Knowledge-Level Scale.](ppa-10-2437Fig3){#f3-ppa-10-2437}

###### 

Respondents' sociodemographic characteristics in relation to their knowledge level

  Nominal (qualitative) variables   Hypertension knowledge level   *P*-value   1 − *β*                          
  --------------------------------- ------------------------------ ----------- --------------- ------ --------- -------
  Sex                                                                                                 0.638     0.071
   Female                           76                             51.7        48              55.8             
   Male                             71                             48.3        38              44.2             
  Education                                                                                                     
   Primary                          36                             24.5        27              31.4   0.254     0.171
   High school                      62                             42.2        37              43.0   0.905     0.037
   College/university               49                             33.3        22              25.6   0.721     0.186
  Professional activity                                                                               0.727     0.252
   Active                           48                             32.6        36              41.9             
   Nonactive                        99                             67.4        50              58.1             
  Living situation                                                                                              
   Living alone                     123                            83.7        13              15.1   \<0.001   1.000
   Living with family/partner       22                             14.9        72              83.7   \<0.001   1.000
   Residential care institution     3                              1.4         1               1.2    0.898     0.010
  Age                                                                                                 0.945     0.054
   M ± SD                           62.9±15.2                                  63.3±14.8                        
   Me (Q~1~; Q~3~)                  64 (55; 75)                                63.5 (54; 74)                    
   Min--Max                         22--90                                     20--90                           

**Abbreviations:** Me, mean; SD, standard deviation; M, median; Q~1~, lower quartile; Q~3~, upper quartile; *P*, confidence level; 1 − *β*, test power; Min, minimum; Max, maximum.

###### 

Respondents' clinical characteristics in relation to knowledge level

  Nominal (qualitative) variables           Hypertension knowledge level   *P*-value   1 − *β*                    
  ----------------------------------------- ------------------------------ ----------- ----------- ------ ------- -------
  BP ≥140 mmHg or ≥90 mmHg                  83                             56.5        26          27.9   0.032   0.989
  ESC hypertension grade                                                                                          
   Normal BP                                16                             10.9        11          12.8   0.662   0.049
   Prehypertension                          26                             17.7        16          18.6   0.863   0.036
   Grade 1 hypertension                     70                             47.6        35          40.7   0.308   0.141
   Grade 2 hypertension                     35                             23.8        24          27.9   0.488   0.083
  Comorbidities                                                                                                   
   Diabetes mellitus                        60                             40.8        31          36.1   0.561   0.083
   COPD                                     50                             34.0        29          33.7   0.922   0.036
   Ischemic heart disease                   46                             31.3        13          15.1   0.010   0.752
   Kidney failure                           34                             23.1        26          30.2   0.298   0.184
  Medication                                                                                                      
   ACE inhibitors                           72                             49.0        42          48.8   0.909   0.036
   Beta-adrenolytics                        25                             17.0        18          20.9   0.569   0.088
   Angiotensin II receptor antagonists      10                             6.8         5           5.8    0.984   0.029
   Thiazide diuretics                       29                             19.7        18          20.9   0.959   0.039
   Calcium channel blockers                 49                             33.3        25          29.1   0.597   0.075
  Treatment type                                                                                                  
   Single-agent treatment                   93                             63.2        56          65.1   0.959   0.043
   Combination treatment                    54                             36.7        30          34.9           
  Other hypertension treatment forms        54                             36.7        38          44.2   0.325   0.168
   Low-sodium/DASH diet                     41                             27.9        26          30.2   0.817   0.049
   Weight reduction                         28                             19.0        20          23.3   0.549   0.096
   Moderate physical activity               36                             24.5        23          26.7   0.821   0.048
  Keeping a self-control diary              54                             36.7        52          64.2   0.048   0.979
  Blood pressure control daily/weekly       52                             35.4        48          57.8   0.044   0.894
  Own blood pressure meter                  86                             58.5        64          77.1   0.052   0.795
  Adherence score (MMAS-8)                                                                                        
   Low                                      29                             19.7        7           8.1    0.019   0.596
   Moderate                                 80                             54.4        46          53.5   0.894   0.038
   High                                     38                             25.9        33          38.4   0.047   0.458
  Time from hypertension diagnosis M ± SD   11.2±8.3                                   12.3±9.2           0.349   0.070
  MMAS-8 (score) M ± SD                     6.45±1.45                                  7.08±1.04          0.001   0.966

**Note:** Use of the ©MMAS is protected by US and International copyright laws. Permission for use is required. A license agreement is available from: Donald E Morisky, MMAS Research (MORISKY) 16636 159th Place SE, Renton WA 98058, <dmorisky@gmail.com>.

**Abbreviations:** M, median; SD, standard deviation; MMAS-8, 8-item Morisky Medication Adherence Scale; COPD, chronic obstructive pulmonary disease; BP, blood pressure; ESC, European Cardiovascular Society; ACE, angiotensin-converting enzyme; 1 − *β*, test power.

###### 

Number (proportions) of correct answers to HK-LS items in the two hypertension knowledge level subgroups

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Item (correct answer)                                                                                                       Hypertension knowledge level   *P*-value   1 − *β*                             
  --------------------------------------------------------------------------------------------------------------------------- ------------------------------ ----------- ----------- ------- --------------- -------------
  1\. High diastolic or systolic blood pressure indicates increased blood pressure (yes)                                      127                            86.4        84          97.7    0.004           0.788

  2\. Increased diastolic blood pressure also indicates increased blood pressure (yes)                                        123                            83.7        81          94.2    0.023           0.580

  3\. Increased blood pressure is the result of aging, so treatment is unnecessary (no)                                       107                            72.8        80          93.0    \<0.001         0.971

  4\. If the medication for increased blood pressure can control blood pressure, there is no need to change lifestyles (no)   78                             53.1        71          82.6    \<0.001         0.997

  5\. If individuals with increased blood pressure change their lifestyles, there is no need for treatment (no)               89                             60.5        78          90.7    \<0.001         0.999

  6\. Individuals with increased blood pressure must take their medication in a manner that makes them feel good (no)         22                             15.0        22          25.6    0.068           0.447

  7\. Drugs for increased blood pressure must be taken every day (yes)                                                        117                            79.6        81          94.2    0.005           0.842

  8\. Individuals with increased blood pressure must take their medication only when they feel ill (no)                       105                            71.4        84          97.7    \<0.001         0.999

  9\. Individuals with increased blood pressure must take their medication throughout their life (yes)                        94                             63.9        80          93.0    \<0.001         0.999

  10\. For individuals with increased blood pressure, the best cooking method is frying (no)                                  98                             66.7        81          94.2    \<0.001         0.999

  11\. For individuals with increased blood pressure, the best cooking method is boiling or grilling (yes)                    95                             64.6        69          80.2    0.018           0.668

  12\. Individuals with increased blood pressure can eat salty foods as long as they take their drugs regularly (no)          48                             32.7        63          73.3    \<0.001         1.000

  13\. Individuals with increased blood pressure must eat fruits and vegetables frequently (yes)                              70                             47.6        76          88.4    \<0.001         1.000

  14\. The best type of meat for individuals with increased blood pressure is red meat (no)                                   26                             17.7        50          58.1    \<0.001         1.000

  15\. The best type of meat for individuals with increased blood pressure is white meat (yes)                                46                             31.3        64          74.4    \<0.001         1.000

  16\. Individuals with increased blood pressure must not smoke (yes)                                                         74                             50.3        70          81.4    \<0.001         0.998

  17\. Individuals with increased blood pressure can drink alcoholic beverages (no)                                           110                            74.8        81          94.2    \<0.001         0.970

  18\. Increased blood pressure can cause strokes, if left untreated (yes)                                                    125                            85.0        86          100.0   \<0.001         0.984

  19\. Increased blood pressure can cause heart diseases, such as heart attack, if left untreated (yes)                       125                            85.0        85          98.8    \<0.001         0.940

  20\. Increased blood pressure can cause premature death if left untreated (yes)                                             126                            85.7        86          100.0   \<0.001         0.977

  21\. Increased blood pressure can cause kidney failure, if left untreated (yes)                                             111                            75.5        85          98.8    \<0.001         0.999

  22\. Increased blood pressure can cause visual disturbances, if left untreated (yes)                                        108                            73.5        82          95.3    \<0.001         0.993

                                                                                                                                                                                                             

  **HK-LS questionnaire domains (M ± SD)**                                                                                    **Low**\                                   **High**\           ***P*-value**   **1 − *β***
                                                                                                                              **N=147**                                  **N=86**                            

                                                                                                                                                                                                             

  Definition                                                                                                                  1.70±0.65                                  1.92±0.28           0.012           0.948

  Treatment                                                                                                                   2.30±1.01                                  3.10±0.55           \<0.001         1.000

  Drug adherence                                                                                                              2.19±1.14                                  3.40±0.69           \<0.001         1.000

  Lifestyle                                                                                                                   3.04±1.15                                  4.48±0.64           \<0.001         1.000

  Diet                                                                                                                        0.49±0.64                                  1.33±0.73           \<0.001         1.000

  Complications                                                                                                               4.05±1.46                                  4.93±0.26           \<0.001         1.000

  Total score (M ± SD)                                                                                                        13.8±3.7                                   19.1±1.1            \<0.001         1.000
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** HK-LS, Hypertension Knowledge-Level Scale; M, median; SD, standard deviation; *P*, significance level; 1 − *β*, test power.

###### 

Proportions of correct answers in HK-LS domains for the two subgroups

  --------------------------------------------------------------------------------
  Domain           Total (%)   Group 1 (%)\   Group 2 (%)\   1 vs 2\     1 − *β*
                               N=147          N=86           *P*-value   
  ---------------- ----------- -------------- -------------- ----------- ---------
  Definition       89.1        85.0           95.9           0.012       0.676

  Treatment        65.9        57.5           77.6           \<0.001     0.857

  Drug adherence   65.9        54.8           84.9           \<0.001     0.998

  Lifestyle        70.7        60.8           87.7           \<0.001     0.995

  Diet             39.9        24.5           66.3           \<0.001     1.000

  Complications    87.5        81.0           98.6           \<0.001     0.988

  Total            71.5        62.6           86.6           \<0.001     
  --------------------------------------------------------------------------------

**Abbreviations:** HK-LS, Hypertension Knowledge-Level Scale; 1 − *β*, test power.

###### 

Single- and multiple-factor regression analysis results for the variables studied against MMAS scores

  Nominal (qualitative) variables                   Single-factor analysis      Multiple-factor analysis                               
  ------------------------------------------------- --------------------------- -------------------------- --------------------------- -------
  Age, years                                        0.019 (−0.106 to 0.146)     0.772                      --                          --
  Female sex                                        0.028 (−0.028 to 0.155)     0.671                      --                          --
  Education                                         0.107 (−0.016 to 0.232)     0.104                      --                          --
  Professional activity -- active                   −0.012 (−0.137 to 0.116)    0.861                      --                          --
  Living situation -- living alone                  −0.080 (−0.206 to 0.050)    0.222                      --                          --
  ESC hypertension grade                            0.082 (−0.041 to 0.208)     0.212                      --                          --
  Duration of hypertension in years                 −0.013 (−0.138 to 0.115)    0.848                      --                          --
  Regular BP measurements                           0.171 (0.049 to 0.294)      0.009                      0.183 (0.051 to 0.296)      0.004
  Diary of self-control                             0.177 (0.055 to 0.300)      0.007                      0.115 (−0.008 to 0.240)     0.089
  Concurrent non-pharmaceutical treatment           0.182 (0.060 to 0.305)      0.006                      0.171 (0.049 to 0.294)      0.006
  Ischemic heart disease                            −0.184 (−0.065 to 0.3070)   0.005                      −0.199 (−0.068 to 0.2980)   0.001
  High level of knowledge on hypertension (HK-LS)   0.173 (0.051 to 0.296)      0.008                      0.208 (0.087 to 0.330)      0.001

**Note:** Use of the © MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, UCLA School of Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.

**Abbreviations:** MMAS, Morisky Medication Adherence Scale; ESC, European Society of Cardiology; BP, blood pressure; HK-LS, Hypertension Knowledge-Level Scale.

###### 

Spearman's rank correlation coefficients (*ρ*) and significance values (*P*) for correlations between HK-LS domains and MMAS-8 scores

  Subdimension        Total        Low knowledge level   High knowledge level
  ------------------- ------------ --------------------- ----------------------
  Definition          *ρ*=0.110    *ρ*=0.062             *ρ*=0.181
  *P*=0.094           *P*=0.451    *P*=0.095             
  Medical treatment   *ρ*=0.079    *ρ*=0.028             *ρ*=0.024
  *P*=0.230           *P*=0.732    *P*=0.826             
  Drug adherence      *ρ*=0.242    *ρ*=0.303             *ρ*=0.029
  *P*\<0.001          *P*\<0.001   *P*=0.789             
  Lifestyle           *ρ*=0.065    *ρ*=−0.022            *ρ*=−0.021
  *P*=0.320           *P*=0.788    *P*=0.845             
  Diet                *ρ*=0.058    *ρ*=−0.024            *ρ*=0.013
  *P*=0.378           *P*=0.771    *P*=0.901             
  Complications       *ρ*=0.068    *ρ*=0.061             *ρ*=−0.140
  *P*=0.301           *P*=0.458    *P*=0.197             
  Total score         *ρ*=0.179    *ρ*=0.151             *ρ*=0.028
  *P*=0.007           *P*=0.068    *P*=0.799             

**Note:** Use of the © MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, UCLA School of Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.

**Abbreviations:** HK-LS, Hypertension Knowledge-Level Scale; MMAS-8, 8-item Morisky Medication Adherence Scale.
